|
|
||||||||
B Mediates the Stimulation of Cytokine and Chemokine Expression by Human Articular Chondrocytes in Response to Fibronectin Fragments1





Departments of
*
Internal Medicine, Section of Rheumatology, and
Department of Biochemistry, Rush Medical College, Chicago, IL 60612; and
Department of Musculoskeletal Diseases, GlaxoSmithKline, Collegeville, PA 19426
Fibronectin fragments (FN-f) that bind to the
5
1 integrin stimulate chondrocyte-mediated cartilage destruction and could play an important role in the progression of arthritis. The objective of this study was to identify potential cytokine mediators of cartilage inflammation and destruction induced by FN-f and to investigate the mechanism of their stimulation. Human articular chondrocytes, isolated from normal ankle cartilage obtained from tissue donors, were treated with a 110-kDa FN-f in serum-free culture, and expression of various cytokine genes was analyzed by cDNA microarray and by a cytokine protein array. Compared with untreated control cultures, stimulation by FN-f resulted in a >2-fold increase in IL-6, IL-8, MCP-1, and growth-related oncogene
(GRO-
). Constitutive and FN-f-inducible expression of GRO-
and GRO-
were also noted by RT-PCR and confirmed by immunoblotting. Previous reports of IL-1
expression induced by FN-f were also confirmed, while TNF expression was found to be very low. Inhibitor studies revealed that FN-f-induced stimulation of chondrocyte chemokine expression was dependent on NF-
B activity, but independent of IL-1 autocrine signaling. The ability of FN-f to stimulate chondrocyte expression of multiple proinflammatory cytokines and chemokines suggests that damage to the cartilage matrix is capable of inducing a proinflammatory state responsible for further progressive matrix destruction, which also includes the chemoattraction of inflammatory cells. Targeting the signaling pathways activated by FN-f may be an effective means of inhibiting production of multiple mediators of cartilage destruction.
This article has been cited by other articles:
![]() |
D. L. Cecil and R. Terkeltaub Transamidation by Transglutaminase 2 Transforms S100A11 Calgranulin into a Procatabolic Cytokine for Chondrocytes J. Immunol., June 15, 2008; 180(12): 8378 - 8385. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ribaux, J. A. Ehses, N. Lin-Marq, F. Carrozzino, M. Boni-Schnetzler, E. Hammar, J.-C. Irminger, M. Y. Donath, and P. A. Halban Induction of CXCL1 by Extracellular Matrix and Autocrine Enhancement by Interleukin-1 in Rat Pancreatic {beta}-Cells Endocrinology, November 1, 2007; 148(11): 5582 - 5590. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Muddasani, J. C. Norman, M. Ellman, A. J. van Wijnen, and H.-J. Im Basic Fibroblast Growth Factor Activates the MAPK and NF{kappa}B Pathways That Converge on Elk-1 to Control Production of Matrix Metalloproteinase-13 by Human Adult Articular Chondrocytes J. Biol. Chem., October 26, 2007; 282(43): 31409 - 31421. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Im, P. Muddasani, V. Natarajan, T. M. Schmid, J. A. Block, F. Davis, A. J. van Wijnen, and R. F. Loeser Basic Fibroblast Growth Factor Stimulates Matrix Metalloproteinase-13 via the Molecular Cross-talk between the Mitogen-activated Protein Kinases and Protein Kinase C{delta} Pathways in Human Adult Articular Chondrocytes J. Biol. Chem., April 13, 2007; 282(15): 11110 - 11121. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gupta, G. Yeo, H. Kawakubo, V. Rangnekar, P. Ramaswamy, T. Hayashida, D. T. MacLaughlin, P. K. Donahoe, and S. Maheswaran Mullerian-Inhibiting Substance Induces Gro-{beta} Expression in Breast Cancer Cells through a Nuclear Factor-{kappa}B-Dependent and Smad1-Dependent Mechanism Cancer Res., March 15, 2007; 67(6): 2747 - 2756. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Leveille, M. Bouillon, W. Guo, J. Bolduc, E. Sharif-Askari, Y. El-Fakhry, C. Reyes-Moreno, R. Lapointe, Y. Merhi, J. A. Wilkins, et al. CD40 Ligand Binds to {alpha}5beta1 Integrin and Triggers Cell Signaling J. Biol. Chem., February 23, 2007; 282(8): 5143 - 5151. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Cecil, K. Johnson, J. Rediske, M. Lotz, A. M. Schmidt, and R. Terkeltaub Inflammation-Induced Chondrocyte Hypertrophy Is Driven by Receptor for Advanced Glycation End Products J. Immunol., December 15, 2005; 175(12): 8296 - 8302. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |